Cassipa

Active Ingredient(s): Buprenorphine + Naloxone
FDA Approved: * September 7, 2018
Pharm Company: * TEVA PHARMS USA INC
Category: Opioid Dependence

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cassipa Overview

Buprenorphine is an opioid used to treat opioid use disorder, acute pain, and chronic pain.[8] It can be used under the tongue (sublingual), in the cheek (buccal), by injection (intravenous and subcutaneous), as a skin patch (transdermal), or as an implant.[8][9] For opioid use disorder, it is typically started when withdrawal symptoms have begun and for the first two days of treatment under direct observation of a health-care provider.[...

Read more Cassipa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Buprenorphine

Recent Cassipa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Buprenorphine + Naloxone
  • Film: 0.075mg, 0.15mg, 0.3mg, 0.45mg, 0.6mg, 0.75mg, 0.9mg, 12mg + 3mg, 150mcg, 16mg + 4mg, 2 mg + 0.5 mg, 2.1mg + 0.3mg, 2mg + 0.5mg, 300mcg, 4.2mg + 0.7mg, 450mcg, 4mg + 1mg, 6.3mg + 1mg, 600mcg, 750mcg, 75mcg, 8 mg + 2 mg, 8mg + 2mg, 900mcg
  • Film, Extended Release: 10mcg/hr, 15mcg/hr, 20mcg/hr, 5mcg/hr, 7.5mcg/hr
  • Implant: 80mg, 80mg/implant
  • Injection: 0.3mg, 0.3mg/ml
  • Injection, Extended Release: 100mg, 300mg
  • Solution, Extended Release: 100mg/0.5ml (100mg/0.5ml), 300mg/1.5ml (200mg/ml)
  • Tablet: 0.7mg + 0.18mg, 1.4mg + 0.36mg, 11.4mg + 2.9mg, 2.9mg + 0.71mg, 2mg, 2mg + 0.5mg, 5.7mg + 1.4mg, 8.6mg + 2.1mg, 8mg, 8mg + 2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (19 results)